May 22, 2018 / 11:39 AM / 3 months ago

BRIEF-PAVmed Q1 Adjusted Non-GAAP Loss Per Share $0.10

May 22 (Reuters) - PAVmed Inc:

* PAVMED REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.10

* Q1 GAAP LOSS PER SHARE $0.21

* REMAIN ON TARGET TO FILE RESUBMISSION RELATED TO CARPX TO U.S. FDA BY END OF MAY

* PAVMED - IDENTIFIED EU NOTIFIED BODY, TAKING ADDITIONAL REQUISITE STEPS TO SUBMIT APPLICATION FOR CE MARK FOR CARPX IN EUROPE, TARGETED FOR LATE Q3

* ALSO TOOK STEPS TO INITIATE A RIGHTS OFFERING WHICH CO EXPECTS TO LAUNCH THIS WEEK

* COMMON STOCK HOLDERS WILL BE GRANTED ONE RIGHT TO PURCHASE A NEW UNIT CONSISTING OF A SHARE OF STOCK AND A SERIES Z WARRANT FOR $2.25 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below